NexImmune Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	5	2	6	105	-
Market Cap Growth	-	-62.95%	-93.94%	-	-
Enterprise Value	1	-1	-27	23	14
PE Ratio	-0.07	-0.07	-0.10	-2.04	-
PB Ratio	1.32	0.67	0.20	1.25	-
P/FCF Ratio	-0.07	-0.07	-0.12	-2.18	-
P/OCF Ratio	-0.07	-0.07	-0.12	-2.29	-
EV/EBITDA Ratio	0.03	0.03	0.45	-0.46	-0.51
EV/EBIT Ratio	0.02	0.02	0.44	-0.46	-0.50
EV/FCF Ratio	0.03	0.03	0.52	-0.47	-0.51
Debt / Equity Ratio	0.02	0.02	0.03	-	-0.28
Debt / EBITDA Ratio	0.00	0.00	-0.02	-	-0.69
Debt / FCF Ratio	0.00	0.00	-0.02	-	-0.70
Quick Ratio	0.63	0.63	3.36	11.35	0.19
Current Ratio	1.06	1.06	3.62	11.96	0.31
Interest Coverage	-	-	-	-55.22	-16.75
Return on Equity (ROE)	-247.20%	-247.20%	-121.20%	-49.90%	59.00%
Return on Assets (ROA)	-167.40%	-167.40%	-102.20%	-46.90%	-265.00%
Return on Capital (ROIC)	-921.43%	-921.43%	-189.29%	-63.58%	55.42%
Earnings Yield	-700.03%	-1376.92%	-985.95%	-48.98%	-
FCF Yield	-681.21%	-1339.91%	-825.99%	-45.98%	-
Buyback Yield / Dilution	-9.05%	-9.05%	-19.19%	-1508.68%	-1.16%
Total Shareholder Return	-9.05%	-9.05%	-19.19%	-1508.68%	-1.16%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).